特異性:Insulin Like Growth Factor I (IGF-I) Somatomedin C The basic IGF-1-like forms (pI>9.0) showed substantial cross-reactivity, as did rat and mouse sera. Monoclonal antibody BM23 was capable of abolishing the biological activities of IGF-1 in-vitro bioassays for insulin-like, mitogenic and sulphation activities.